PIK3CA and lymphangioma: Accumulating evidence has shown that mutations in the phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) gene are found more frequently in LECs than in fibroblasts in LM patients (Blesinger et al., 2018).